FLT1 and diabetes mellitus: In order to know whether VEGFR1 blockade can also be therapeutically effective or reverse the disease progression, it would be necessary to treat mice at a later stage when complications of diabetes have already taken place because DR is a chronic ischemic and inflammatory disorder and many diabetes-associated complications start appearing at relatively later stages.